Julie Milot
Overview
Explore the profile of Julie Milot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maltais F, Milot J
Ther Adv Respir Dis
. 2012 Oct;
6(6):345-61.
PMID: 23075544
Long-acting muscarinic antagonists (LAMAs) play a central role in the management of chronic obstructive pulmonary disease (COPD). Previously, only one LAMA (tiotropium) was available for the treatment of COPD, necessitating...
12.
Gagnon P, Saey D, Provencher S, Milot J, Bourbeau J, Tan W, et al.
Respir Med
. 2012 Sep;
106(12):1695-705.
PMID: 22999808
Rationale: Patients with mild chronic obstructive pulmonary disease (COPD) present abnormal ventilatory mechanics during exercise and may require bronchodilator therapy. However, bronchodilation does not enhance cycling exercise tolerance in these...
13.
Mainguy V, Girard D, Maltais F, Saey D, Milot J, Senechal M, et al.
Am J Cardiol
. 2012 Apr;
110(2):258-63.
PMID: 22497677
Cardioselective β blockers are considered to have little impact on lung function at rest in patients with chronic obstructive pulmonary disease (COPD). However, their effects on dynamic hyperinflation, an important...
14.
Morissette M, Parent J, Milot J
Respir Res
. 2011 Aug;
12:105.
PMID: 21824395
Background: Alveolar apoptosis is increased in the emphysematous lung. However, mechanisms involved are not fully understood. Recently, we demonstrated that levels of TRAIL receptor 1 and 2, levels of p53,...
15.
Laviolette L, Lands L, Dauletbaev N, Saey D, Milot J, Provencher S, et al.
J Med Food
. 2010 Jun;
13(3):589-98.
PMID: 20521985
Pressurized whey supplementation, by its antioxidant and nutritional properties, may improve exercise tolerance and potentiate the effects of exercise training in patients with chronic obstructive pulmonary disease (COPD). In this...
16.
Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, et al.
J Appl Physiol (1985)
. 2009 Jul;
107(3):832-40.
PMID: 19574500
Exercise intolerance in chronic obstructive pulmonary disease (COPD) results from a complex interaction between central (ventilatory) and peripheral (limb muscles) components of exercise limitation. The purpose of this study was...
17.
Morissette M, Parent J, Milot J
Int J Chron Obstruct Pulmon Dis
. 2009 May;
4:19-31.
PMID: 19436685
Emphysema is mainly caused by cigarette smoking and is characterized by the loss of alveolar integrity and an enlargement of the alveolar space. However, mechanisms involved in its development are...
18.
Morissette M, Vachon-Beaudoin G, Parent J, Chakir J, Milot J
Am J Respir Crit Care Med
. 2008 May;
178(3):240-7.
PMID: 18511705
Rationale: Emphysema is mainly known for the complex inflammatory processes associated with its development. In addition to lung inflammation, it is now accepted that increased alveolar cell apoptosis is also...
19.
Semlali A, Jacques E, Plante S, Biardel S, Milot J, Laviolette M, et al.
Am J Respir Cell Mol Biol
. 2007 Sep;
38(2):202-8.
PMID: 17872498
Epithelial damage is an important pathophysiologic feature of asthma. Bronchial epithelium damage results in release of growth factors such as transforming growth factor (TGF)-beta(1) that may affect epithelial cell proliferation....
20.
Morissette M, Parent J, Milot J
Respir Res
. 2007 Sep;
8:62.
PMID: 17822550
Background: It is generally accepted that emphysematous lungs are characterized by an increase in the numbers of neutrophils, macrophages, and CD8+ T lymphocytes, the lasts having increased cytotoxic activity. Because...